Once the $600k interest is dealt with (paid off, etc.),
Once the $600k interest is dealt with (paid off, etc.), the financial picture brightens considerably.
BIEL’s Gross Margins Are Elite — ~85%
ActiPatch’s ~85% gross margin means BIEL is operationally profitable at very low revenue levels.
This is why the company only needs a modest revenue bump to cross into positive cash flow.
Cash-Flow Positive Could Happen in 2026
BIEL only needs to cover:
~$350k annual overhead
Manufacturing costs
The Taiwan stocking orders (May 2026) and the Electrome distribution deal (targeting 3,700 pharmacies by Q3 2026) are expected to provide enough cash to flip operational cash flow positive this year.
This is the inflection point. Electrome can make this revenue level a reality quickly.
CASH-FLOW, PROFITABILITY, PPS PROJECTIONS
Assumptions:
85% gross margin
$350k annual operating expenses
$600k interest is paid off
Revenue = Gross Profit = Operating Profit = GAAP Net = Cash Flow Reality
$1 Million Revenue
Gross Profit: $850k
Operating Profit: $500k
GAAP Net: $500k
Cash-Flow: +$500k (cash-flow positive/profitable)
est PPS = .01
$6 Million Revenue
Gross Profit: $5.1M
Operating Profit: $4.75M
GAAP Net: +$4.75M
est. PPS = .02 (P/E = 1000)
$9 Million Revenue
Gross Profit: $7.65M
Operating Profit: $7.65M
GAAP Net: +$7.65M
est. PPS = .03 (P/E = 1000)
The $500,000+ (2025) revenue base and the $41M tax-loss carryforward accelerates profitability.
1
BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Sales Focus Inc.: Leading the Way in Healthcare Outsourcing Sales Focus Inc. (SFI) proudly announces its recognition as the Top Healthcare and Medical Sales Outsourcing Service for 2025. This prestigious accolade showcases the company's vital role in revolutionizing the healthcare sector with its innovative full-lifecycle sales execution model and robust industry...
Continue Reading
Exploring the Autonomous Data Platform Market Growth The world of data management is rapidly evolving, with the Autonomous Data Platform Market projected to reach an impressive USD 14.96 billion by 2032. This explosive growth expands at a significant CAGR of 27.89% from its current valuation, representing a fundamental shift in how organizations interact with their data....
Continue Reading
Insider Purchase by William Abbey at Enpro In the latest SEC filing, the market received noteworthy news about Enpro. William Abbey, who serves as a Director at Enpro (NYSE:NPO), demonstrated significant confidence in the company by purchasing 567 shares for a total of $139,997. What This Purchase Indicates This insider transaction suggests a strong belief in Enpro's...
Continue Reading
BNB Donation Achieves Remarkable Growth Recently, an incredible story surfaced about the untouched donation made in BNB (CRYPTO: BNB) for cancer patients. This donation, originally valued at $200,000, has soared to an astonishing $39 million thanks to the surging market value of cryptocurrencies, particularly BNB. Impact of Cryptocurrency Fluctuation on Charity Funds...
Continue Reading
Bio X Cell Unveils a Fresh Brand Identity Bio X Cell, recognized as the global leader in functional antibodies tailored for in vivo and emerging preclinical models, has introduced a modernized brand identity. This change is a testament to nearly three decades of excellence in the field, seamlessly merging scientific innovation with expanding global capabilities in...
Continue Reading